Loading...
Loading...
GEHC| Name | Value |
|---|---|
| Revenues | 5,206.0M |
| Cost of Revenue | 3,050.0M |
| Gross Profit | 2,156.0M |
| Operating Expense | 1,467.0M |
| Operating I/L | 689.0M |
| Other Income/Expense | -80.0M |
| Interest Income | 7.0M |
| Pretax | 609.0M |
| Income Tax Expense | 193.0M |
| Net Income/Loss | 403.0M |
GE HealthCare Technologies Inc. develops, manufactures, and markets a wide range of products, services, and digital solutions for the diagnosis, treatment, and monitoring of patients globally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. Its Imaging segment offers molecular imaging, CT scanning, MR imaging, image-guided therapy, and X-ray systems. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring solutions, while the Patient Care Solutions segment offers medical devices, consumables, and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents, contrast media pharmaceuticals, and molecular imaging agents to the radiology and nuclear medicine industry.
